118 related articles for article (PubMed ID: 37149081)
1. Renewal of oligodendrocyte lineage reverses dysmyelination and CNS neurodegeneration through corrected N-acetylaspartate metabolism.
Lotun A; Li D; Xu H; Su Q; Tuncer S; Sanmiguel J; Mooney M; Baer CE; Ulbrich R; Eyles SJ; Strittmatter L; Hayward LJ; Gessler DJ; Gao G
Prog Neurobiol; 2023 Jul; 226():102460. PubMed ID: 37149081
[TBL] [Abstract][Full Text] [Related]
2. NAAG synthetase deficiency has only low influence on pathogenesis in a Canavan disease mouse model.
Becker I; Wang-Eckhardt L; Eckhardt M
J Inherit Metab Dis; 2024 Mar; 47(2):230-243. PubMed ID: 38011891
[TBL] [Abstract][Full Text] [Related]
3. Developing Hypoimmunogenic Human iPSC-Derived Oligodendrocyte Progenitor Cells as an Off-The-Shelf Cell Therapy for Myelin Disorders.
Feng L; Chao J; Ye P; Luong Q; Sun G; Liu W; Cui Q; Flores S; Jackson N; Shayento ANH; Sun G; Liu Z; Hu W; Shi Y
Adv Sci (Weinh); 2023 Aug; 10(23):e2206910. PubMed ID: 37271923
[TBL] [Abstract][Full Text] [Related]
4. Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model.
Guo F; Bannerman P; Mills Ko E; Miers L; Xu J; Burns T; Li S; Freeman E; McDonough JA; Pleasure D
Ann Neurol; 2015 May; 77(5):884-8. PubMed ID: 25712859
[TBL] [Abstract][Full Text] [Related]
5. Redirecting
Gessler DJ; Li D; Xu H; Su Q; Sanmiguel J; Tuncer S; Moore C; King J; Matalon R; Gao G
JCI Insight; 2017 Feb; 2(3):e90807. PubMed ID: 28194442
[TBL] [Abstract][Full Text] [Related]
6. Increasing N-acetylaspartate in the Brain during Postnatal Myelination Does Not Cause the CNS Pathologies of Canavan Disease.
Appu AP; Moffett JR; Arun P; Moran S; Nambiar V; Krishnan JKS; Puthillathu N; Namboodiri AMA
Front Mol Neurosci; 2017; 10():161. PubMed ID: 28626388
[TBL] [Abstract][Full Text] [Related]
7. Pathological Bergmann glia alterations and disrupted calcium dynamics in ataxic Canavan disease mice.
Hull VL; Wang Y; Burns T; Sternbach S; Gong S; McDonough J; Guo F; Borodinsky LN; Pleasure D
Glia; 2023 Dec; 71(12):2832-2849. PubMed ID: 37610133
[TBL] [Abstract][Full Text] [Related]
8. Myelin lesion in the aspartoacylase (Aspa) knockout rat, an animal model for Canavan disease.
Takeda S; Hoshiai R; Tanaka M; Izawa T; Yamate J; Kuramoto T; Kuwamura M
Exp Anim; 2024 Mar; ():. PubMed ID: 38538326
[TBL] [Abstract][Full Text] [Related]
9. Astroglial conditional Slc13a3 knockout is therapeutic in murine Canavan leukodystrophy.
Hull VL; Wang Y; McDonough J; Zhu M; Burns T; Al Ramel N; Dehghani A; Guo F; Pleasure D
Ann Clin Transl Neurol; 2024 Apr; 11(4):1059-1062. PubMed ID: 38282243
[TBL] [Abstract][Full Text] [Related]
10. Evidence That DDR1 Promotes Oligodendrocyte Differentiation during Development and Myelin Repair after Injury.
Mei R; Qiu W; Yang Y; Xu S; Rao Y; Li Q; Luo Y; Huang H; Yang A; Tao H; Qiu M; Zhao X
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373466
[TBL] [Abstract][Full Text] [Related]
11. Dual-function AAV gene therapy reverses late-stage Canavan disease pathology in mice.
Fröhlich D; Kalotay E; von Jonquieres G; Bongers A; Lee B; Suchowerska AK; Housley GD; Klugmann M
Front Mol Neurosci; 2022; 15():1061257. PubMed ID: 36568275
[TBL] [Abstract][Full Text] [Related]
12. N-Acetylaspartate Drives Oligodendroglial Differentiation via Histone Deacetylase Activation.
Dominicis A; Del Giovane A; Torreggiani M; Recchia AD; Ciccarone F; Ciriolo MR; Ragnini-Wilson A
Cells; 2023 Jul; 12(14):. PubMed ID: 37508525
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease.
Grønbæk-Thygesen M; Hartmann-Petersen R
Cell Biosci; 2024 Apr; 14(1):45. PubMed ID: 38582917
[TBL] [Abstract][Full Text] [Related]
14. Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis.
López-Muguruza E; Matute C
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629092
[TBL] [Abstract][Full Text] [Related]
15. rAAV Gene Therapy in a Canavan's Disease Mouse Model Reveals Immune Impairments and an Extended Pathology Beyond the Central Nervous System.
Ahmed SS; Schattgen SA; Frakes AE; Sikoglu EM; Su Q; Li J; Hampton TG; Denninger AR; Kirschner DA; Kaspar B; Matalon R; Gao G
Mol Ther; 2016 Jun; 24(6):1030-1041. PubMed ID: 27039844
[TBL] [Abstract][Full Text] [Related]
16. N-acetyl-aspartate metabolism at the interface of cancer, immunity, and neurodegeneration.
Krause N; Wegner A
Curr Opin Biotechnol; 2024 Feb; 85():103051. PubMed ID: 38103520
[TBL] [Abstract][Full Text] [Related]
17. N-acetylaspartate from fat cells regulates postprandial body temperature.
Felix JB; Saha PK; de Groot E; Tan L; Sharp R; Anaya ES; Li Y; Quang H; Saidi N; Abushamat L; Ballantyne CM; Amos CI; Lorenzi PL; Klein S; Gao X; Hartig SM
Res Sq; 2024 Jan; ():. PubMed ID: 38260478
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation.
Corti M; Byrne BJ; Gessler DJ; Thompson G; Norman S; Lammers J; Coleman KE; Liberati C; Elder ME; Escolar ML; Tuna IS; Mesaros C; Kleiner GI; Barbouth DS; Gray-Edwards HL; Clement N; Cleaver BD; Gao G
Mol Ther Methods Clin Dev; 2023 Sep; 30():303-314. PubMed ID: 37601414
[TBL] [Abstract][Full Text] [Related]
19. Oligodendroglial Energy Metabolism and (re)Myelination.
Tepavčević V
Life (Basel); 2021 Mar; 11(3):. PubMed ID: 33805670
[TBL] [Abstract][Full Text] [Related]
20. Utilizing hiPSC-derived oligodendrocytes to study myelin pathophysiology in neuropsychiatric and neurodegenerative disorders.
Shim G; Romero-Morales AI; Sripathy SR; Maher BJ
Front Cell Neurosci; 2023; 17():1322813. PubMed ID: 38273973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
